Hyperprolactinemia

Ask specifically about progressive visual symptoms and assess for headache or other manifestations of an expanding sellar lesion. Obtain contrast-enhanced pituitary MRI when persistent hyperprolactinemia remains unexplained, and arrange formal visual-field testing when a macroadenoma is adjacent to or compressing the optic chiasm. PubMed+1PubMedHyperprolactinemia - StatPearls - NCBI BookshelfPubMedBest Practice Recommendations for Infertility Management

Interpret the prolactin result in clinical context rather than treating an isolated laboratory abnormality. Pregnancy, breastfeeding, stress, exercise, food intake, sleep, chronic kidney or liver failure, primary hypothyroidism, hypothalamic-pituitary stalk compression, and medications can each raise prolactin. PubMed+1PubMedApproach to the Patient With Prolactinoma - PMCPubMedHyperprolactinemia - Endotext - NCBI Bookshelf

For confirmed prolactin elevation in a patient of childbearing potential, obtain pregnancy testing. At the same evaluation, perform a targeted medication reconciliation for dopamine receptor blockers, dopamine-depleting or dopamine synthesis-inhibiting drugs, antipsychotics and neuroleptics, antidepressants, gastrointestinal medications, and oral contraceptives. PubMed+2PubMedApproach to the Patient With Prolactinoma - PMCPubMedBest Practice Recommendations for Infertility ManagementPubMedHyperprolactinemia - Endotext - NCBI Bookshelf

Measure TSH with free or total T4 and assess renal function; evaluate hepatic failure when clinically relevant. Primary hypothyroidism accounts for hyperprolactinemia in approximately 20% to 40% of affected patients, and prolactin generally normalizes after treatment of hypothyroidism. PubMed+2PubMedHyperprolactinemia in women: diagnostic approachPubMedBest Practice Recommendations for Infertility ManagementPubMedHyperprolactinemia - Endotext - NCBI Bookshelf

When pregnancy, lactation, medication exposure, thyroid disease, renal or hepatic failure, and relevant hypothalamic-pituitary lesions have been excluded, obtain contrast-enhanced MRI of the pituitary. MRI is preferred; CT is an alternative when MRI is unavailable. PubMed+2PubMedHyperprolactinemia in women: diagnostic approachPubMedBest Practice Recommendations for Infertility ManagementPubMedHyperprolactinemia - Endotext - NCBI Bookshelf

In asymptomatic patients, or in those with scant evidence of prolactin excess and prolactin below 250 μg/L, screen for macroprolactin before ordering pituitary MRI. Polyethylene glycol precipitation is used to detect macroprolactin; macroprolactinemia is common enough that screening can avoid unnecessary imaging and treatment. PubMed+2PubMedApproach to the Patient With Prolactinoma - PMCPubMedBest Practice Recommendations for Infertility ManagementPubMedHyperprolactinemia - Endotext - NCBI Bookshelf

Suspect the hook effect when a pituitary tumor larger than 3 cm is paired with prolactin of roughly 30 to 120 ng/mL, or whenever tumor burden is disproportionate to a mild or moderate prolactin elevation. Repeat the assay on serial dilution, with at least 1:100 dilution recommended; the artifact results from antigen excess causing a falsely low immunoradiometric assay result. PubMed+3PubMedHyperprolactinemia - StatPearls - NCBI BookshelfPubMedHyperprolactinemia in women: diagnostic approachPubMedApproach to the Patient With Prolactinoma - PMCPubMedBest Practice Recommendations for Infertility Management

Resolving this discrepancy changes management materially: an undiluted low result may falsely suggest a nonfunctioning macroadenoma with stalk effect and lead toward unnecessary surgery, whereas a corrected markedly elevated prolactin supports macroprolactinoma. PubMed+1PubMedHyperprolactinemia in women: diagnostic approachPubMedHyperprolactinemia - Endotext - NCBI Bookshelf

Classify a pituitary prolactinoma by maximal diameter: microprolactinoma is less than 10 mm, macroprolactinoma exceeds 10 mm, and giant prolactinoma exceeds 4 cm. Microprolactinomas are more prevalent in women, whereas macroprolactinomas are more prevalent in men. PubMed+1PubMedProlactinoma - StatPearls - NCBI BookshelfPubMedApproach to the Patient With Prolactinoma - PMC

A biochemical-radiographic match supports prolactinoma: microadenomas have been associated with prolactin around 94 to 188 ng/mL, and macroprolactinomas commonly exceed 235 ng/mL. By contrast, hypothalamic dysfunction or stalk compression generally produces concentrations below 94 ng/mL, although prolactin is more useful as a rule-in than a rule-out measure. PubMedPubMedCorrelation between MRI findings of pituitary gland and prolactin ...

When the clinical syndrome is overt and prolactin exceeds 250 μg/L, prolactinoma is strongly supported and gadolinium-enhanced pituitary MRI should define tumor extent. When a sellar lesion is large but prolactin is not commensurately high, repeat the assay after dilution before concluding that stalk effect explains the elevation. PubMed+1PubMedPitfalls in the Diagnostic Evaluation of Hyperprolactinemia - PubMedPubMedApproach to the Patient With Prolactinoma - PMC

For pregnancy, lactation, medication-induced elevation, hypothyroidism, renal or hepatic failure, or stalk-related hyperprolactinemia, address the underlying condition rather than automatically initiating prolactinoma therapy. Treatment of primary hypothyroidism can normalize prolactin; medication review is essential because dopamine-blocking and related agents are established causes of symptomatic hyperprolactinemia. PubMed+2PubMedHyperprolactinemia in women: diagnostic approachPubMedApproach to the Patient With Prolactinoma - PMCPubMedHyperprolactinemia - Endotext - NCBI Bookshelf

For macroprolactinemia without a compatible clinical syndrome, avoid unnecessary pituitary imaging and treatment after confirmation by polyethylene glycol precipitation. PubMed+1PubMedBest Practice Recommendations for Infertility ManagementPubMedHyperprolactinemia - Endotext - NCBI Bookshelf

For prolactinoma-associated hypogonadotropic hypogonadism, dopamine agonist therapy can reverse hypogonadism. The available evidence identifies dopamine agonists, including cabergoline and bromocriptine, as established prolactinoma therapies, but dose initiation, titration, withdrawal criteria, and surveillance intervals should be individualized using current product labeling and specialty guidance. BMJ+3BMJDiagnosis and management of prolactinomas and non-functioning ...Oxford AcademicHormonal Replacement in Hypopituitarism in Adults: An Endocrine ...Oxford AcademicNeuro-Oncology - Oxford AcademicPubMedProlactinoma - StatPearls - NCBI Bookshelf

Counsel patients considering pregnancy that hyperprolactinemia and prolactinoma require preconception coordination, particularly for macroadenomas where visual and tumor-anatomic status matter. Pregnancy was not associated with recurrence of hyperprolactinemia in one long-term follow-up report and is not inherently contraindicated, but management should account for individual tumor size and prior treatment. Oxford Academic+1Oxford AcademicLong Term Follow-UpPubMedProlactinoma - StatPearls - NCBI Bookshelf